JPH022861B2 - - Google Patents
Info
- Publication number
- JPH022861B2 JPH022861B2 JP56101665A JP10166581A JPH022861B2 JP H022861 B2 JPH022861 B2 JP H022861B2 JP 56101665 A JP56101665 A JP 56101665A JP 10166581 A JP10166581 A JP 10166581A JP H022861 B2 JPH022861 B2 JP H022861B2
- Authority
- JP
- Japan
- Prior art keywords
- improvement
- amantadine hydrochloride
- present
- patient
- hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10166581A JPS584718A (ja) | 1981-06-30 | 1981-06-30 | 新規適応症に用うる医薬製剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10166581A JPS584718A (ja) | 1981-06-30 | 1981-06-30 | 新規適応症に用うる医薬製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS584718A JPS584718A (ja) | 1983-01-11 |
| JPH022861B2 true JPH022861B2 (enExample) | 1990-01-19 |
Family
ID=14306662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10166581A Granted JPS584718A (ja) | 1981-06-30 | 1981-06-30 | 新規適応症に用うる医薬製剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS584718A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9382640B2 (en) | 2011-12-12 | 2016-07-05 | Shin-Etsu Quartz Products Co., Ltd. | Single crystal silicon pulling silica container and manufacturing method thereof |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6444702B1 (en) | 2000-02-22 | 2002-09-03 | Neuromolecular, Inc. | Aminoadamantane derivatives as therapeutic agents |
| CA2436311A1 (en) * | 2000-12-07 | 2002-06-13 | Neuromolecular Inc. | Methods for treating neuropsychiatric disorders with nmda receptor antagonists |
| US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
| EP1874282B1 (en) | 2005-04-06 | 2010-09-15 | Adamas Pharmaceuticals, Inc. | Methods and compositions for treatment of cns disorders |
| BR112012013487A2 (pt) | 2009-12-02 | 2017-10-03 | Adamas Pharmaceuticals Inc | Composições de amantadina e métodos de uso |
| US10154971B2 (en) | 2013-06-17 | 2018-12-18 | Adamas Pharma, Llc | Methods of administering amantadine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4148896A (en) * | 1978-02-22 | 1979-04-10 | E. I. Du Pont De Nemours And Company | Antidepressant combination |
-
1981
- 1981-06-30 JP JP10166581A patent/JPS584718A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9382640B2 (en) | 2011-12-12 | 2016-07-05 | Shin-Etsu Quartz Products Co., Ltd. | Single crystal silicon pulling silica container and manufacturing method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS584718A (ja) | 1983-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6235962B2 (ja) | オキシコドンおよびナロキソンを含有する剤形 | |
| WO2008005345A2 (en) | Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditions | |
| JP6137833B2 (ja) | 脱髄性および他の神経系疾患を患っている患者における神経認知的および/または神経精神医学的障害を改善するための4−アミノピリジンの使用 | |
| Aronow et al. | Childhood poisoning: an unfortunate consequence of methadone availability | |
| KR20150067168A (ko) | 기억력 증진용 향정신성 조성물 | |
| JPH09323927A (ja) | 慢性閉塞性動脈硬化症の治療のためのカルニチン誘導体含有薬剤 | |
| KR20170120708A (ko) | 탈수초를 갖는 환자에서 4-아미노피리딘을 사용한 지속적 치료 | |
| JP4276779B2 (ja) | 注意欠損/活動亢進症の治療のためのアルカノイルカルニチン誘導体の使用 | |
| JPH022861B2 (enExample) | ||
| CN110831590A (zh) | 含有培马贝特的医药 | |
| US20160220563A1 (en) | Selective dopamine d4 receptor agonists for treatment of working memory deficits | |
| JP2022554231A (ja) | 過敏性腸症候群の予防又は治療のための医薬的組み合わせ | |
| Oliveto et al. | D-cycloserine--naloxone interactions in opioid-dependent humans under a novel-response naloxone discrimination procedure. | |
| WO2025162430A1 (zh) | 一种药物联用及其在预防或治疗神经退行性疾病中的用途 | |
| Budhiraja | Elementary Pharmacology & Toxicology 4e | |
| Banerjee et al. | 100 Cases in Clinical Pharmacology | |
| Pauling | Compound-65 | |
| JPWO2005027968A1 (ja) | ダウン症候群治療剤 | |
| JPH08119858A (ja) | 自閉症治療剤 | |
| Saint-Hyacinthe | T/CMIDAZOLAM INJECTION USP | |
| HK1219669A1 (en) | Dosage form containing oxycodone and naloxone |